Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-28

Clinical Trial Update: A Prospective Clinical Trial to Evaluate the Efficacy and Safety of Neurotropic B-Vitamins in Clinically Diagnosed Peripheral Sensory Polyneuropathy of Different Etiologies. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating neurotropic B-vitamins for peripheral sensory polyneuropathy of various etiologies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Procter and Gamble | Conditions: Peripheral Sensory Neuropathy of Different Etiologies | Phase 3 | Status: COMPLETED